Moffitt Cancer Center’s Cutaneous Oncology Program specializes in the evaluation and treatment of patients with melanoma and other skin cancers like basal and squamous cell carcinoma, Merkel cell carcinoma, and dermatofibrosarcoma protuberans.
Our team of skin cancer specialists – surgeons, medical oncologists, a dermatologist, dermatopathologist, radiologist, radiation oncologist, nurses and other health care professionals – provides a comprehensive program of care for patients. That includes screening, diagnosis, staging and treatment for skin cancer, as well as long-term follow up, both at Moffitt and in coordination with a patient’s primary physician closer to home.
As the only Florida-based National Cancer Institute-designated Comprehensive Cancer Center, Moffitt and the Cutaneous Oncology Program offer the latest investigational treatments for melanoma. Our program physicians have been pioneers in developing and defining the role of lymphatic mapping and sentinel node biopsy for staging of patients with clinically negative nodes, as well as investigating adjuvant therapy for both node-negative and node-positive patients. Surgical treatment of selected patients with in-transit and metastatic melanoma also is a fundamental part of the approach to patients with more advanced disease.